agilon health, inc. (NYSE:AGL) Receives $3.95 Consensus Price Target from Brokerages

agilon health, inc. (NYSE:AGL) has earned an average recommendation of “Hold” from the seventeen research firms that are presently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have assigned a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $3.95.

AGL has been the topic of a number of research analyst reports. Macquarie started coverage on shares of agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective on the stock. Stifel Nicolaus increased their price objective on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a report on Wednesday, February 26th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Royal Bank of Canada increased their price objective on shares of agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Finally, Citigroup raised agilon health from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $1.75 to $2.25 in a report on Friday, January 10th.

agilon health Stock Performance

AGL stock opened at $4.14 on Friday. agilon health has a twelve month low of $1.50 and a twelve month high of $7.73. The business’s fifty day moving average is $3.74 and its 200-day moving average is $2.99. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market cap of $1.70 billion, a P/E ratio of -4.40 and a beta of 0.38.

Hedge Funds Weigh In On agilon health

A number of hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock worth $59,114,000 after acquiring an additional 272,787 shares during the period. Capital International Investors boosted its position in agilon health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after purchasing an additional 9,346,295 shares during the last quarter. State Street Corp grew its stake in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after purchasing an additional 215,733 shares during the period. Millennium Management LLC increased its position in shares of agilon health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after purchasing an additional 4,706,357 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of agilon health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock worth $13,168,000 after purchasing an additional 35,207 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.